These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23621170)

  • 1. Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.
    Saraceno R; Camplone G; D'Agostino M; De Simone C; Di Cesare A; Filosa G; Frascione P; Gabellini M; Lunghi F; Mazzotta A; Peris K; Scotto Di Luzio G; Calvieri S; Simonacci M; Chimenti S
    J Dermatolog Treat; 2014 Feb; 25(1):30-3. PubMed ID: 23621170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL
    Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
    Liu L; Zhang C; Wang J; Chen K; Ding Y; Yan G; Lu Q; Li W; Fang H; Cheng H; Zhang J; He Y; Zhu W; Lu Y; Huang J; Pan W; Li M; Cao S; Li S; Han X; He L; Chen Y; Zheng M
    Eur J Dermatol; 2020 Oct; 30(5):580-590. PubMed ID: 33052103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
    Jemec GB; van de Kerkhof PC; Enevold A; Ganslandt C
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):27-32. PubMed ID: 20456557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.
    Lee JH; Park CJ; Kim TY; Choe YB; Kim NI; Song HJ; Youn JI; Youn SW; Choi JH; Kim KJ
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):483-489. PubMed ID: 27723134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
    Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.
    Kragballe K; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
    Ma L; Yang Q; Yang H; Wang G; Zheng M; Hao F; Gu J; Sun Q; Cui P; Ge M; Li R; Gao T; Facy P; Kurvits M; Xu Z; Xu J
    Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
    Queille-Roussel C; Hoffmann V; Enevold A; Ganslandt C
    J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment and improvement of quality of life in patients with scalp psoriasis by topical use of calcipotriol/betamethasone (Xamiol®-gel): results.
    Mrowietz U; Macheleidt O; Eicke C
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):825-31. PubMed ID: 21564540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
    Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
    Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.
    Gooderham M; Debarre JM; Keddy-Grant J; Xu Z; Kurvits M; Goodfield M
    Br J Dermatol; 2014 Dec; 171(6):1470-7. PubMed ID: 24980277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.